Circular Genomics recently moved its headquarters to Lilly Gateway Labs, aiming to enhance its Alzheimer's disease ...

On February 10, the company announced a collaboration with AdvanCell to advance cancer treatment through targeted alpha therapies. By combining Eli Lilly and Company’s (NYSE:LLY) expertise in drug ...

Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of ...

On February 10, the company announced a collaboration with AdvanCell to advance cancer treatment through targeted alpha therapies. By combining Eli Lilly and Company’s (NYSE:LLY) expertise in ...

The company also represents Advancell expandable microspheres, and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion ...

Other companies are looking at lead-212 RLTs, meanwhile, including ARTBIO and POINT Biopharma/AdvanCell, but Orano Med is thought to be in the lead in the category. Sanofi's chief executive Paul ...

The company also expanded its research collaboration with AdvanCell to develop targeted cancer therapies and formed a venture capital fund aimed at therapeutic platform innovation. Additionally, ...

On February 10, the company announced a collaboration with AdvanCell to advance cancer treatment through targeted alpha ...

The company also expanded its research collaboration with AdvanCell to develop targeted cancer therapies and formed a venture capital fund aimed at therapeutic platform innovation. Additionally, ...